President Trump Criticized Marijuana Odors in Cities
The president linked city marijuana usage to crime during recent remarks.
Updated on Oct. 10, 2026 in Drug Crime
President Trump described sidewalks and streets in Democrat-run cities as disgusting, alleging that the smell of marijuana in these areas is linked to criminal activity. These comments were made while his administration continues the federal process of reclassifying cannabis.
Why it matters
The president has maintained a long-standing position on marijuana, having previously suggested links between the drug and issues like mass shootings and IQ decline. His administration is currently navigating the legal process of moving marijuana from Schedule I to Schedule III status.
Attorney General Todd Blanche issued an order in April 2026 reclassifying state-licensed medical cannabis to Schedule III. A separate hearing is currently considering moving all remaining marijuana categories to Schedule III.
The players
Donald Trump
Donald Trump serves as the current President of the United States.
Todd Blanche
Todd Blanche serves as the Attorney General of the United States.
The details
President Trump highlighted his concerns about urban environments during a Columbus Day speech. The administration's regulatory shift targets FDA-approved products and state-licensed medical cannabis, aiming to adjust their federal scheduling under the Controlled Substances Act.
Timeline
In 2020, Trump claimed marijuana use causes IQ problems.
In 2023, Trump suggested a link between genetically engineered marijuana and mass shootings.
In April 2026, Attorney General Blanche issued a reclassification order.
On October 9, 2026, President Trump delivered a speech on Columbus Day.
Legal Context
The federal process of reclassifying marijuana is governed by the framework established in the Controlled Substances Act. This regulatory shift marks a departure from historical federal classifications that have categorized the drug as having no accepted medical use.
The potential rescheduling of marijuana could alter the legal landscape for state-licensed medical cannabis access across the country. Residents in major urban centers may observe changing enforcement priorities as the administration balances federal policy with local issues.
The takeaway
The federal government is currently in the midst of a significant regulatory review regarding marijuana status. Tracking these administrative changes remains essential for understanding how national drug policy may impact state-level medical markets in the future.
Further reading
For more information on national legislative trends, visit the Drug Crime section.
